Page 3 - புழ்ழ் காட்டு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புழ்ழ் காட்டு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புழ்ழ் காட்டு Today - Breaking & Trending Today

"The Buzz" Show: Ocuphire Pharma (NASDAQ: OCUP) Phase 2 Study Endpoint in Presbyopic Patients | Financial Buzz"The Buzz'' Show: Ocuphire Pharma (NASDAQ: OCUP) Phase 2 Study Endpoint in Presbyopic Patients


FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Ocuphire Pharma, Inc (NASDAQ: OCUP) Surges After VEGA-1 Phase 2 Trial Met Study Endpoints In Presbyopic Patients”
Ocuphire Pharma, Inc. (NASDAQ: OCUP) surged over 40% in premarket trading after the company’s VEGA-1 Phase 2 Trial in Presbyopia Met its Primary and Secondary Endpoints.
Key secondary endpoints on visual acuity and pupil diameter showed statistical significance and the Company now plans to advance into Phase 3 registration trials.
Ocuphire is a publicly traded (NASDAQ: OCUP), clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire’s pipeline currently includes two small-molecule product candidates targeting front and back of the eye indications. The company’s lead product candidate, Nyxol® (0.75% phentolamine ophthalmic solution) Eye Drops, is a once-daily pres ....

Ocuphire Pharma Inc , Buzz Show , Featuring Our Corporate News Recap , Surges After , Met Study Endpoints In Presbyopic , Presbyopia Met , Eye Drops , Ocuphire Pharma , புழ்ழ் காட்டு , இடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப் , கண் சொட்டுகள் ,

"The Buzz" Show: Exela Technologies, Inc. (NASDAQ: XELA) Rollout of EON, Robotic Processing | Financial Buzz"The Buzz'' Show: Exela Technologies, Inc. (NASDAQ: XELA) Rollout of EON, Robotic Processing


FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Exela Technologies, Inc. Surges Amid Providing EON Automation Platform to Health Insurance Company”
Exela Technologies, Inc. (NASDAQ: XELA) surged over 51% in premarket trading after the company announced the rollout of EON, Exela’s Robotic Process Automation platform for a large health insurance company.
This effort accelerates the digital transformation efforts for a major insurer by automating repetitive manual tasks, and is currently utilized by several customers across multiple industries including Banking, Finance & Accounting and the Public Sector.
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. ....

Exela Technologies Inc , Automation Platform To Health Insurance Company , Buzz Show , Featuring Our Corporate News Recap , Surges Amid Providing , Health Insurance , Robotic Process Automation , Exela Technologies , புழ்ழ் காட்டு , இடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப் , ஆரோக்கியம் காப்பீடு , ரோபோடிக் ப்ரோஸெஸ் ஆட்டோமேஷன் ,

"The Buzz" Show: Bionano Genomics, Inc. (NASDAQ: BNGO) Joins US Small-Cap Russell 2000® Index | Financial Buzz"The Buzz'' Show: Bionano Genomics, Inc. (NASDAQ: BNGO) Joins US Small-Cap Russell 2000® Index


Posted on
FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Bionano Genomics, Inc. up 6% after Becoming a Member of US Small-Cap Russell 2000® Index”
Bionano Genomics, Inc. (NASDAQ: BNGO) gained over 6% in premarket trading after the Company said it was added as a member of the US small-cap Russell 2000® Index, effective as of the Market open on June 28th.
Membership in the Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index, with the indexes widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. ....

Bionano Saphyr , Bionano Genomics Inc , Buzz Show , Featuring Our Corporate News Recap , Cap Russell , Bionano Genomics , புழ்ழ் காட்டு , இடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப் , தொப்பி ரஸ்ஸல் ,

"The Buzz" Show: Intellia Therapeutics, Inc. (NASDAQ: NTLA) Positive Gene Editing Data | Financial Buzz"The Buzz'' Show: Intellia Therapeutics, Inc. (NASDAQ: NTLA) Positive Gene Editing Data


FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Intellia Therapeutics, Inc. Surges Following Positive Gene Editing Data”
Intellia Therapeutics, Inc. (NASDAQ: NTLA) surged over 59% in premarket trading after the Company and Regeneron Pharmaceuticals announced positive interim data from an ongoing Phase 1 clinical study of their lead in vivo genome editing candidate, NTLA-2001.
The Phase 1 study of a single-dose treatment for ATTR is evaluating the first CRISPR/Cas9-based therapy candidate to be administered systemically, via intravenous infusion, for precision editing of a gene in a target tissue in humans.
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics using CRISPR/Cas9 technology. To fully realize the transformative potential of CRISPR/Cas9, Intellia is pursuing two primary approaches. The company’s ....

Regeneron Pharmaceuticals , Intellia Therapeutics Inc , Buzz Show , Featuring Our Corporate News Recap , Surges Following Positive Gene Editing , Intellia Therapeutics , புழ்ழ் காட்டு , இடம்பெறும் அவர் பெருநிறுவன செய்தி ரீக்யாப் ,